Trademarkia Logo

Australia

AU$
FYVAPENT
Cancelled: Cancelled at the request of IB

Last updated on 17 Oct 2023

Owner Info

MATINAS BIOPHARMA HOLDINGS, INC.

1545 Route 206 South, Suite 302

Bedminster NJ 07921, UNITED STATES OF AMERICA

Serial Number

2091731 filed on 1 May 2020

Correspondent

Vanessa A. Ignacio, Esq. Lowenstein Sandler LLP

One Lowenstein Drive,

Roseland NJ 07068,

UNITED STATES OF AMERICA

FYVAPENT

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cardiovascular and metabolic conditions, which are available by prescription; pharmaceutical preparat Read More

Mark Details


Serial Number

2091731

Registered On

1 May 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

27 Apr 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
17th Oct 2023Status change to Voided
8th Dec 2020International Registration in Australia Protected correspondence sent
7th Dec 2020IP Right Registration Published
7th Dec 2020Status change to Registered/Protected
30th Sept 2020Application Accepted correspondence sent
28th Sept 2020IP Right has been Examined
28th Sept 2020IP Right Acceptance Published
14th Sept 2020Status change to Accepted
28th May 2020Awaiting examination
28th May 2020Examination expedited